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Abstract 
Intense training is the most clinically successful treatment modality following 
incomplete spinal cord injuries (SCIs). With the advent of plasticity enhancing 
treatments, understanding how treatments might interact when delivered in 
combination becomes critical. Here, we investigated a rational approach to 
sequentially combine treadmill locomotor training with antibody mediated 
suppression of the fiber growth inhibitory protein Nogo-A. Following a large but 
incomplete thoracic lesion, rats were immediately treated with either anti-Nogo-A or 
control antibody (2 weeks) and then either left untrained or step-trained starting 3 
weeks after injury for 8 weeks. It was found that sequentially combined therapy 
improved step consistency and reduced toe dragging and climbing errors, as seen with 
training and anti-Nogo-A individually. Animals with sequential therapy also adopted 
a more parallel paw position during bipedal walking and showed greater overall 
quadrupedal locomotor recovery than individual treatments. Histologically, sequential 
therapy induced the greatest corticospinal tract sprouting caudally into the lumbar 
region and increased the number of serotonergic synapses onto lumbar motoneurons. 
Increased primary afferent sprouting and synapse formation onto lumbar motoneurons 
observed with anti-Nogo-A antibody were reduced by training. Animals with 
sequential therapy also showed the highest reduction of lumbar interneuronal activity 
associated with walking (c-fos expression). No treatment effects for thermal 
nociception, mechanical allodynia, or lesion volume were observed. The results 
demonstrate that sequential administration of anti-Nogo-A antibody followed in time 
with intensive locomotor training leads to superior recovery of lost locomotor 
functions, which is probably mediated by changes in the interaction between 
descending sprouting and local segmental networks after SCI.  
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1. Introduction 
Despite numerous treatments being tested in animal experiments and clinical 
trials, no cure has been found for spinal cord injury (SCI) (Thuret et al., 2006). 
Individual treatments may result in some functional improvements, but they will 
unlikely emerge as panaceas for SCI; rather, tailored combinations of treatments with 
a scientific basis are proposed to be potential therapies that will lead to cumulative 
improvements in SCI outcomes (Thuret et al., 2006; Edgerton et al., 2008; van Hedel 
and Dietz, 2010; Fouad and Tetzlaff, 2012; Starkey and Schwab, 2012). Particularly, 
locomotor training is presently the most clinically successful treatment to promote 
functional recovery after different central nervous system (CNS) injury types, and it is 
becoming routine for incomplete SCI patients in rehabilitation centers worldwide 
(Raineteau and Schwab, 2001; Dietz and Harkema, 2004; Thuret et al., 2006; van 
Hedel and Dietz, 2010; Marsh et al., 2011; Fouad and Tetzlaff, 2012; Starkey and 
Schwab, 2012). Moreover, suppression of Nogo-A, one of the most restrictive growth 
inhibitory molecules in the adult CNS which is up-regulated upon neuronal damage, 
is a promising pharmacological treatment to promote axonal regeneration, sprouting, 
and functional recovery after a variety of CNS injuries in preclinical tests (Raineteau 
and Schwab, 2001; Schwab, 2004; Thuret et al., 2006; Pernet and Schwab, 2012; 
Starkey and Schwab, 2012; Schwab and Strittmatter, 2014). Human antibodies against 
Nogo-A have been tested in Phase I clinical trials in ASIA category A patients and are 
being prepared for a placebo-controlled Phase II clinical trial (Pernet and Schwab, 
2012; Starkey and Schwab, 2012). It is hoped that a rational strategy can be 
developed to combine these treatments to maximize behavioral recovery after SCI 
(Thuret et al., 2006; Fouad and Tetzlaff, 2012; Starkey and Schwab, 2012). 
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We previously examined the effects of anti-Nogo-A antibody treatment and 
treadmill training in rats with incomplete thoracic SCI; individual treatments 
improved locomotor performance compared to no treatment, but their simultaneous 
application showed no locomotor improvement (Maier et al., 2009). Similarly, Nogo 
Receptor 1 (NgR1) gene deletion and multimodal training alone were shown to 
improve functional recovery in a mouse model of mild cervical SCI, but their 
combined effect caused no functional improvement (Harel et al., 2010). Since the 
recovery mechanisms of Nogo-A suppression and training were not only different but 
also possibly competitive, their simultaneous application might have negatively 
interfered with each other’s pathological and functional development after SCI; 
therefore, timing between interventions may be critical for combination therapies to 
reach their full potential (Maier et al., 2009; Starkey and Schwab, 2012). This notion 
is supported by our recent study in a rat model of large forebrain cortex stroke 
demonstrating that sequential application of anti-Nogo-A treatment followed by 
intensive forelimb reaching training resulted in almost completely restored skilled 
forelimb functions associated with organized fiber sprouting patterns, but their 
simultaneous application led to poorer functional outcomes compared to individual 
treatments and no treatment associated with aberrant fiber sprouting patterns (Wahl et 
al., 2014). 
Based on these findings, we hypothesized that sequential combination of Nogo-
A suppression and rehabilitative training would lead to cumulative improvements in 
SCI outcomes when compared to either treatment alone. To test this hypothesis, the 
present study investigated the individual and combined sequential effects of anti-
Nogo-A antibody treatment for the first 2 weeks and treadmill training starting 3 
weeks for 8 weeks after incomplete thoracic SCI in rats. 
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2. Materials and methods 
2.1 Animals 
All procedures were approved by the UK Home Office and performed under 
the Animals (Scientific Procedures) Act 1986. Twenty-eight female Sprague-Dawley 
rats (200-250 g) were obtained from Charles River (Margate, UK). Animals were 
housed individually on a 12-hour light-dark cycle at 19-21C with 45-65% humidity 
and fed standard chow and water ad libitum. They were acclimated to the facility and 
handled for 7 days before surgery. No animals were excluded from final analysis. 
 
2.2 SCI induction and antibody treatment 
Animals were anesthetized with isoflurane (5% induction and 1.5% 
maintenance in O2) and maintained on a heat pad throughout the surgical procedure. 
Their backs were shaved and cleaned with povidone-iodine. Ophthalmic ointment was 
applied to the eyes to prevent drying. 
Under aseptic conditions, a dorsal midline incision was made from 
approximately T8 to L3. The skin and muscles were retracted to expose the vertebral 
column. A laminectomy was performed between T9 and T10, and the dorsomedial, 
dorsolateral, and ventromedial parts of the corticospinal tract (CST) were transected 
at T9 with iridectomy scissors (i.e. a T-shaped lesion) (Liebscher et al., 2005; Maier 
et al., 2009). 
Animals were blindly and randomly treated with either mouse monoclonal 
IgG1 anti-Nogo-A antibody 11C7 (kindly supplied by Novartis, Basel, Switzerland) 
or control antibody mouse monoclonal IgG1 anti-cyclosporin A (ACsA, Novartis) (n 
= 14 for each antibody) (Oertle et al., 2003; Zhao et al., 2013). Osmotic pumps (Alzet 
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2ML2, Durect Co., Cupertino, USA) were filled with 11C7 or ACsA, attached to 
custom-made catheters (0.702 mm inner diameter, 00702, Detakta, Norderstedt, 
Germany and 0.108 mm inner diameter, 0041, ReCathCo, Allison Park, USA and), 
and placed in bottles with sterile saline in a 37°C water bath on the day before surgery. 
Following SCI, a partial laminectomy was performed to open a hole at L2. The 
large/proximal part of the catheter was anchored to the paravertebral muscles caudal 
to the hole with sutures, and the small/distal part of the catheter was inserted into the 
subdural space through the hole, and pushed rostrally to T10. The pump body was 
implanted subcutaneously and continuously delivered the antibody into the 
cerebrospinal fluid through the catheter for 2 weeks (2 ml, 5 μl/hr, 3 mg IgG/ml). For 
each day of surgery the same number of 11C7 and ACsA pumps were implanted in a 
blinded and random fashion. 
 The muscles and skin were sutured in layers. Animals were placed in an 
incubator until they regained consciousness and then were returned to their cages. 
Baytril (2.5 mg/kg), buprenorphine (0.015 mg/kg), and saline (10 ml) were 
administered subcutaneously at 0, 24, and 48 hours after surgery. Bladders were 
manually expressed twice daily until reflex bladder emptying returned; thereafter, 
animals were checked at least once daily. The osmotic pumps were removed after 2 
weeks. 
 
2.3 Basso, Beattie, Bresnahan (BBB) scale 
 General locomotor activity of the animals in an open field was measured 
weekly after SCI using the BBB locomotor rating scale (Basso et al., 1995).  
 
2.4 Locomotor training 
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Before training began, the two antibody treatment groups were further divided 
into four counterbalanced groups: ACsA+ untrained (UT), ACsA+ step-trained (ST), 
11C7+UT, and 11C7+ST (n = 7 in each group, BBB scores three weeks after SCI 
were around 12 for both ACsA+UT and ACsA+ST groups and around 14 for both 
11C7+UT and 11C7+ST groups, Fig. 1a). 
 For the step-trained groups, training started 3 weeks after injury (i.e., 1 week 
following the end of antibody treatment) and consisted of bipedal walking on a body-
weight support (BWS) treadmill system (Rodent Robot 3000, Robomedica Inc., Irvine, 
USA) for 20 minutes followed by quadrupedal walking on a rat dual lane treadmill 
(760303, Harvard Apparatus, Cambridge, UK) for 20 minutes (Maier et al., 2009). 
During bipedal walking, the head and upper body of the animals were placed in the 
cloth tube that was attached to the computer-controlled BWS device, and the amount 
of BWS was adjusted according to individual ability. Their hindlimbs stepped on the 
treadmill at 7 cm/s first and then gradually increased to 21 cm/s by week 4 of training. 
Similarly, quadrupedal walking started at 7 cm/s and 0% grade and reached 21 cm/s 
and 10% grade by week 4 of training. Training was conducted 5 days per week for 8 
weeks. The untrained animals were handled as often as the step-trained animals. 
 
2.5 Walking pattern 
Bipedal walking of the animals on the BWS treadmill system was measured 
11 weeks after SCI. Their lateral hindlimb areas were shaved, and 3-mm-diameter 
retro-reflective markers were placed on the skin overlaying the anatomical landmarks 
of iliac crest, greater trochanter, lateral epicondyle of the femur, lateral malleolus, and 
fifth digit distal phalange. The three-dimensional position of the markers was 
recorded using a seven-camera motion capture system (Nexus software and Bonita 
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cameras, Vicon, Oxford, UK) at 100 Hz, while animals walked bipedally at 14 cm/s 
for 10 consecutive steps provided with individually adjusted BWS. Collected data 
were transformed to Cartesian coordinates and analyzed using custom software in 
MATLAB (MathWorks, Natick, USA). Toe drag, paw position, and step consistency 
were measured to assess functional recovery of the animals. 
Toe drag normally does not occur during walking in rats, but they often drag 
their toes after SCI (Basso et al., 1995; Maier et al., 2009). Toe drag of the animals 
was quantified by the percent time that their toes were in contact with the treadmill 
belt (toe raise ≤ 1 mm) in the swing phase, and the beginning and end of the stance 
and swing phases of the step cycle were indicated by the extremes of forward and 
backward motion (i.e. change of position) of the toes. Values were averaged over the 
10 step cycles and between left and right sides. 
Hind paws are normally placed parallel to the body at lift off and initial 
contact during walking in rats, but after SCI they are frequently rotated inward or 
outward (Basso et al., 1995). Paw position of the animals at lift off and initial contact 
and throughout swing were measured by the plane angle between the direction of the 
treadmill and a straight line connecting the ankle and toe markers. Values were 
averaged over the 10 step cycles and between left and right sides. 
Walking pattern is normally very consistent in rats, but their steps often 
become less consistent after SCI (Maier et al., 2009). Spatial stepping consistency of 
the animals was quantified using principal component analysis. Cartesian coordinate 
data from an anatomical landmark were evenly resampled to remove temporal 
variation among the 10 step cycles, and the data for each of the three axes were 
arranged into a matrix with columns and rows representing the steps and resampled 
time series, respectively. The matrices were transformed into principal components, 
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and the percentage of variance explained by the first principal components was 
averaged and used to assess step consistency; the higher the average variance 
explained, the more consistent the walking pattern of that landmark. Step consistency 
was analyzed with all the anatomical landmarks, and the same analysis was 
previously performed with toe movement in two and three dimensions (Fong et al., 
2005; Maier et al., 2009). Values were averaged between left and right sides. 
 
2.6 Inclined climbing 
 Climbing ability of the animals was measured on a custom inclined climbing 
apparatus 11 weeks after SCI (Maier et al., 2009). The climbing apparatus consists of 
two rows of eight individual platforms alternating between left and right with an 
incline of 10°. The design allows normal rats to climb the apparatus platform-by-
platform on the left and right sides by placing one paw on a platform at a time 
consistently. The platforms are movable, and distances between the platforms were 
randomly ordered at the beginning of each trial to prevent the animals from learning 
the task. To encourage them to reach the top of the apparatus from the bottom, their 
cages were ported to the top of the apparatus with the presence of food rewards (Froot 
Loops, Kellogg's, Battle Creek, USA).  
 Animals were habituated to the climbing apparatus and testing procedure 1 
week before measurement. On the day of measurement, they were placed at the 
bottom of the apparatus to climb to the top in three trials, and cameras were placed on 
one side of the apparatus to record the trials at 60 f/s. Errors were counted from the 
video recordings and averaged over trials, and an error was scored when a platform 
was skipped by a paw, multiple attempts were made to place a paw on a platform, 
placement was made on a platform by any part of the body other than the plantar 
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surface of a paw, or a paw slipped off a platform at lift off. Values were averaged 
over the three trials and between left and right sides. 
 
2.7 Nociception assays 
Response of the animals to noxious stimuli was tested after the other 
behavioral tests were completed. Thermal nociception was measured using the 
Hargreaves method (Hargreaves et al., 1988). Animals were acclimated to a Plantar 
Test Apparatus (Ugo Basile, Varese, Italy) for at least 30 minutes before testing. The 
radiant heat source was positioned under the glass floor directly beneath the plantar 
surface of the hind paw, and the infrared intensity was adjusted with a constant 
voltage power supply to obtain a baseline response time of approximately 12 seconds 
in normal animals during the test. The latency of hind paw withdrawal was 
automatically recorded by the apparatus. Values were averaged between left and right 
sides. 
 Mechanical (tactile) allodynia was measured using calibrated von Frey 
filaments (Stoelting, Wood Dale, USA). Animals were placed in a plastic cage with a 
wire mesh bottom and allowed to acclimate for at least 30 minutes before testing. The 
filaments were applied to the mid-plantar surface of the hind paw through the mesh 
floor during the test. The 50% withdrawal threshold was determined using the up-
down method (Chaplan et al., 1994). Values were averaged between left and right 
sides. 
 
2.8 BDATracing 
After behavioral data collection was completed, the CST was traced by 
injections of the anterograde tracer biotin dextran amine (BDA; 10000 MW; 
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Invitrogen, Carlsbad, USA) into the sensorimotor cortex. The procedure was 
performed under aseptic conditions while animals were anesthetized with isoflurane. 
A small hole was drilled into the skull 1 mm lateral and 1 mm posterior to  bregma. A 
total of 3 μl of 10% BDA in 0.01 M phosphate-buffered saline (PBS) was injected 
unilaterally at four sites of the sensorimotor cortex using a Hamilton syringe (Maier et 
al., 2009). 
 
2.9 Tissue preparation 
 Animals were euthanized 12 weeks after SCI. They walked on the treadmill 
(quadrupedal, 21 cm/s, 0% grade) for 1 hour and then returned to their cages for 1 
hour before euthanasia. Animals were killed with an overdose of sodium 
pentobarbital (100 mg/kg ip) and transcardially perfused with 4% paraformaldehyde 
in phosphate buffer. 
Spinal cords were removed, postfixed in the same fixative overnight at 4°C, 
cryoprotected in 30% sucrose in PBS for at least 48 hours at 4°C, embedded in OCT 
compound (Tissue-Tek, Sakura Finetek, Torrance, USA), frozen, and kept at -80°C. 
Sagittal sections of the thoracic spinal cord containing the lesion site were cut at 25 
μm in a cryostat, transferred to adhesive-coated slides using the CryoJane Tape-
Transfer System (Leica, Buffalo Grove, USA), and stored at -80°C. Coronal sections 
of the spinal cord at C7 and from T13 to L5 were cut at 25 μm in the cryostat, 
collected as free-floating sections in PBS, and stored in cryoprotectant at -20°C. 
 
2.10 Lesion size 
 Every spinal cord section containing the lesion site was photographed under a 
microscope in bright-field mode (EC Plan-Neofluar 2.5x/0.075; LSM 510, Carl Zeiss, 
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Jena, Germany). The lesion was manually outlined on the images using Reconstruct 
(Fiala, 2005). The software then reconstructed the lesion and calculated the lesion 
volume. 
 
2.11 BDA staining 
 Six replicate sections of the spinal cord at the cervical (C7), thoracic (T13), 
and lumbar (L1) levels were processed for BDA immunohistochemistry. Sections 
were treated with 0.3% H2O2 in TNT buffer (distilled water, 0.1 M Tris-HCI, 0.15 M 
NaCl, 0.3% Triton X-100; Sigma-Aldrich, St. Louis, USA) for 20 minutes to quench 
endogenous peroxidase activity and blocked in TNB buffer (distilled water, 0.1 M 
Tris-HCI, 0.15 M NaCl, 0.5% blocking reagent; TSA Biotin Kit, PerkinElmer, 
Waltham, USA) for 30 minutes. They were sequentially incubated with avidin-biotin 
complex reagent (1:100, 30 min; Vectastain Elite ABC Kit Standard, Vector 
Laboratories, Burlingame, USA) in TNT buffer, Streptavidin-HRP (1:100, 30 min; 
TSA Biotin Kit) in TNT buffer, biotinyl tyramide in amplification diluent (1:75, 10 
min; TSA Biotin Kit), and ExtrAvidin−FITC (1:500, 30 min; Sigma-Aldrich) in TNT 
buffer, including three 5-minute washes in TNT buffer after each step. Sections were 
mounted on slides and coverslipped with Fluoromount-G (SouthernBiotech, 
Birmingham, USA). 
 BDA-labeled fibers were manually located and counted at T13 and L1 under a 
confocal laser scanning microscope (Plan-Apochromat 40x/1.4; LSM 880, Carl Zeiss), 
and they were photographed at C7 and automatically measured using particle analysis 
in ImageJ (NIH, Bethesda, USA). To compensate for tracing variability, the number 
of fibers at T13 and L1 were normalized to the number of fibers at C7. 
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2.12 Analysis of 5-hydroxytryptamine (5-HT) 
Six replicate sections of the spinal cord segment L4 were processed for 5-HT 
immunohistochemistry. Sections were washed three times for 10 minutes each in PBS, 
blocked with 10% normal donkey serum (Sigma-Aldrich) in PBST (PBS containing 
0.2% Triton X-100) for 1 hour, and incubated with primary antibodies against 5-HT 
(rabbit, 1:18000; Immunostar, Hudson, USA) for 24 hours and choline 
acetyltransferase (ChAT) (goat, 1:500; Millipore, Watford, UK) for 48 hours in 
blocking solution at 4°C. They were washed (3 x 10 min), incubated with secondary 
antibodies conjugated to Alexa Fluor 555 (donkey anti-rabbit, 1:500; Life 
Technologies) and Alexa Fluor 488 (donkey anti-goat, 1:500; Life Technologies, 
Paisley, UK) for 2 hours in blocking solution, washed again (3 x 10 min), and 
mounted for microscopy. 
 Images of the ventral horn were captured using the tile scan function of the 
confocal microscope (40x). 5-HT varicosities in close apposition to motoneurons 
relative to the cell perimeter were measured manually using ImageJ (Maier et al., 
2009). Cells with a minor axis of less than 25 μm were not measured, to substantially 
exclude the gamma motoneurons. 
 
2.13 Analysis of vesicular glutamate transport 1 (VGluT1) 
The same procedure was carried out for VGluT1 staining on six replicate 
sections of the spinal cord segment L2. Primary antibodies were anti-VGluT1 
antibody (guinea pig, 1:10000, 24 hr; Millipore) and the anti-ChAT antibody. 
Secondary antibodies were biotin-SP-conjugated IgG (donkey anti-guinea pig, 1:500, 
2 hr; Jackson ImmunoResearch, West Grove, USA) and the Alexa Fluor 488 dye. 
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Binding of biotinylated reagents was revealed by Alexa Fluor 555-conjugated 
streptavidin (1:500, 2 hr; Life Technologies). 
 Sections were photographed under the confocal microscope (40x). The density 
of VGluT1 puncta was obtained by measuring the number of VGluT1 positive dots in 
the regions of interest (ROIs) using MATLAB (Fig. 3a). In addition, VGluT1 positive 
boutons in close apposition to large motoneurons (minor axis ≥ 25 μm) relative to the 
perimeter of the soma and proximal dendrites were measured manually using ImageJ. 
The puncta density of all the treatment groups was normalized to the puncta density 
of the ACsA+UT group in the intermediate region. 
 
2.14 c-fos expression 
 The same procedure was also carried out for c-fos staining on six replicate 
sections of the spinal cord segments L2-L5. Primary antibody was anti-c-fos antibody 
(rabbit, 1:500, 24 hr; Biotechnology, Santa Cruz, USA). Secondary antibody was the 
Alexa Fluor 555 dye (donkey anti-rabbit). Images of the sections were captured using 
the tile scan function of the confocal microscope (Plan-Apochromat 20x/0.8), and c-
fos positive neurons were counted manually in each lamina according to the 
cytoarchitectonic organization of the spinal cord using Image-Pro-Plus (Media 
Cybernetics, Silver Springs, USA) (Molander et al., 1984). 
 
2.15 Statistical analysis 
All data (i.e. functional assessment and histological analysis) were obtained by 
observers blinded to treatment allocation. For all kinematics, climbing test, sensory 
test, lesion volume, CST and  5-HT counts  a two-way factorial ANOVAwas used to 
test the differences between training (trained vs non-trained) and antibody (11C7 vs 
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IgG). When a significant main effect was found, Duncan’s multiple range post-hoc 
test was used for all statistical tests. . For cfos analysis, a two-way ANOVA was 
performed to test differences between training (trained vs non-trained) and antibody 
(11C7 vs IgG) for each lamina. Because trends were similar between segments, data 
from all lumbar enlargement segments were combined (L2 to L5). Finally, for the 
BBB results a one-waymixed-mode ANOVA (treatments) with repeated measures 
(weeks) was used to determine differences between groups across all time points 
(ACsA+UT, ACsA+ST, 11C7+UT, 11C7+ST). Statistical analysis was performed 
using SPSS (IBM, Chicago, USA). Data are presented as mean ± SEM. Significances 
are indicated as follows: *P < 0.05, **P < 0.01, ***P < 0.001. 
 
3. Results 
3.1 BBB score 
Training and antibody had a significant main effect on open-field locomotor 
activity (training week 8/9/10/11: p = 0.043/0.017/0.015/0.030, F = 4.6/6.7/7.0/5.4; 
antibody week 8/9/10/11: p = 0.011/0.039/0.029/0.011, F = 7.8/4.8/5.5/7.8). The 
11C7+ST group continuously showed significantly better recovery than the 
ACsA+UT,  ACsA+ST, and 11C7+UT groups after 8 weeks post-injury (Fig. 1a). 
 
3.2 Dragging 
Antibody had a significant main effect on toe drag during walking (p = 0.003, 
F = 11). The 11C7+UT and 11C7+ST groups spent less percent time dragging during 
the swing phase than the ACsA+UT and ACsA+ST groups (Fig. 1b). Noticeably, the 
11C7+UT and 11C7+ST groups generally lifted their toes off the treadmill belt earlier 
and raised the toes to a maximum height lower than the ACsA+UT and ACsA+ST 
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groups, making no statistical difference in the average toe height during the swing 
phase between the groups (ACsA+UT 12.3 ± 1.9 mm, ACsA+ST 10.3 ± 0.9 mm, 
11C7+UT 13.3 ± 1.8 mm, 11C7+ST 16.8 ± 2.4 mm) (Fig. 1c). 
 
3.3 Paw position 
 Training and antibody had a significant main effect on paw position during the 
swing phase (training p = 0.024, F = 5.9; antibody p = 0.037, F = 5.0), and training 
also had a significant main effect on paw position at lift off (p = 0.027, F = 5.7) and 
initial contact (p = 0.017, F = 6.8). The 11C7+ST group adopted a more parallel paw 
position than the ACsA+UT group during the swing phase and at lift off and initial 
contact, the 11C7+ST group also adopted a more parallel paw position than the 
11C7+UT group at initial contact, and the ACsA+ST group adopted a more parallel 
paw position than the ACsA+UT group at lift off (Fig. 1d). Noticeably, the 11C7+ST 
group generally kept the paw more parallel to the body throughout swing than the 
other groups (Fig. 1e). Overall, the 11C7+ST group maintained a more parallel paw 
position than the ACsA+UT group in 10 consecutive steps (p < 0.05, ACsA+UT 41.7 
± 4.6°, ACsA+ST 35.9 ± 4.5°, 11C7+UT 38.1 ± 11.3°, 11C7+ST 29.4 ± 8.5°). 
 
3.4 Step consistency 
 Training had a significant main effect on stepping consistency of the crest (p = 
0.006, F = 9.5), hip (p = 0.003, F = 11), knee (p = 0.030, F = 5.4), ankle (p = 0.037, F 
= 5.0), toe (p = 0.045, F = 4.5) and overall hindlimb (p = 0.014, F = 7.3) movement. 
The ACsA+ST group showed more consistent proximal joint (crest and hip) and 
overall hindlimb movement than the ACsA+UT group, and the 11C7+ST group 
showed more consistent proximal joint, distal joint (knee, ankle, and toe), and overall 
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movement than the ACsA+UT group (Fig. 1f). The differences were evident by 
comparing the repeatability of the step trajectories between the groups (Fig. 1g). 
 
3.5 Climbing error 
Antibody had a significant main effect on climbing error (p = 0.022, F = 6.1). 
The 11C7+UT and 11C7+ST groups showed a significant 45 and 42% reduction of 
climbing errors compared to the ACsA+UT group respectively, and there was no 
statistical difference in the ACsA+ST group (Fig. 1h). 
 
3.6 Pain 
Training and antibody had no effect on pain threshold in nociception assays. 
The latency of hind paw withdrawal from the heat source (ACsA+UT 13.6 ± 1.2 s, 
ACsA+ST 12.4 ± 1.1 s, 11C7+UT 12.8 ± 0.7 s, 11C7+ST 15.0 ± 1.3 s) and the 50% 
withdrawal threshold to von Frey filaments (ACsA+UT 11.3 ± 2.3 g, ACsA+ST 10.0 
± 2.4 g, 11C7+UT 12.0 ± 1.7 g, 11C7+ST 14.9 ± 0.1 g) were similar between the 
groups. 
 
3.7 Injury severity 
 All animals were confirmed to have a T-shaped lesion in reconstruction. The 
lesion volume was similar between the groups (ACsA+UT 4.4 ± 0.3 mm3, ACsA+ST 
5.0 ± 0.7 mm3, 11C7+UT 4.5 ± 0.6 mm3, 11C7+ST 5.4 ± 0.6 mm3). 
 
3.8 Supraspinal axons 
BDA labeled CST axons projected caudally mainly in the dorsal funiculus 
with minor components in the lateral and ventral funiculi above the lesion at the 
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cervical level (Fig. 2a). The CST was completely transected at T9. Sprouting CST 
fibers were assessed at T13 and L1; growth appeared caudal and transverse in the 
white matter (WM) (Fig. 2b), it became mainly transverse in and across the gray 
matter (GM) (Fig. 2c), and decussation across the midline near the central canal (CC) 
was occasionally seen in the ACsA+ST group at T13 and the 11C7+ST group at L1 
(Fig. 2d). 
Training and antibody had a significant main effect (training T13/L1: p = 
0.001/0.001, F = 43/550; antibody T13/L1: p = 0.001/0.001, F = 1100/150) and 
interaction (T13/L1: p = 0.001/0.001, F = 15/170) on sprouting CST fibers. At T13, 
the ACsA+ST group had more fibers than the ACsA+UT group, and the 11C7+UT 
and 11C7+ST groups had more fibers than the ACsA+UT and ACsA+ST groups; 
however at L1, the ACsA+ST group had more fibers than the ACsA+UT and 
11C7+UT groups, and the 11C7+ST group had more fibers than the other groups (Fig. 
2e). The 11C7+UT group revealed a greater reduction of fiber growth between T13 
and L1 than the other groups (Fig. 2f). In addition, fibers appeared to be distributed 
more widely in the ACsA+ST, 11C7+UT, and 11C7+ST groups than the ACsA+UT 
group at T13, and from T13 to L1, they appeared to spread further transversely in the 
ACsA+UT, ACsA+ST, and 11C7+ST groups but not in the 11C7+UT group (Fig. 2g). 
 The ventral lateral funiculi were spared by the transection, and serotonergic 
innervation of motoneurons was quantified by 5-HT positive varicosities in close 
apposition to the motoneurons in the lumbar spinal cord (Maier et al., 2009). Training 
and antibody had a significant interaction on serotonergic synaptic density around 
motoneurons (p = 0.012, F = 7.6). The 11C7+ST group had 49, 86, and 70% more 
synapses on motoneurons than the ACsA+UT, ACsA+ST, and 11C7+UT groups, 
respectively (Fig. 2h). 
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3.9 Sensory afferents 
After CST transection, VGluT1 is almost exclusively localized in primary 
afferent fibers and their terminals on spinal neurons (Oliveira et al., 2003; Du Beau et 
al., 2012). Training and antibody had a significant main effect on VGluT1 positive 
fiber density in the dorsal, intermediate, and ventral gray matter of the lumbar spinal 
cord (training dorsal/intermediate/ventral: p = 0.001/0.001/0.014, F =  23/15/7.2; 
antibody dorsal/intermediate/ventral: p = 0.001/0.001/0.001, F = 27/24/28). In the 
dorsal and intermediate regions, the ACsA+ST group had fewer fibers than the other 
groups, and the 11C7+UT group had more fibers than the ACsA+UT group (Fig. 3b). 
In the ventral region, the 11C7+UT group had more fibers than the other groups, and 
the 11C7+ST group had more fibers than the ACsA+ST group. The differences were 
evident when comparing the VGluT1 positive area and intensity in the ROIs between 
the groups (Fig. 3c). 
 Furthermore, antibody had a significant main effect on number of VGluT1 
positive terminals in close apposition to motoneuron somata and dendrites 
(somata/dendrites: p = 0.001/0.001, F = 37/14), and training and antibody had a 
significant interaction on VGluT1 positive terminal density around motoneuron 
dendrites (p = 0.009, F = 8.3). The 11C7+UT and 11C7+ST groups had more 
terminals on motoneuron somata than the ACsA+UT and ACsA+ST groups, and the 
11C7+UT group also had more terminals on motoneuron dendrites than the other 
groups (Fig. 3d). 
 
3.10 Activation of c-fos 
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Elevated c-fos levels in neurons as detected by immunohistochemistry reflect 
neuronal activity in the lumbar spinal cord, and the number and pattern of c-fos 
positive neurons change over time after incomplete SCIs, from a large number of 
diffusely activated cells to a smaller number of specific locomotion circuit neurons 
(Ichiyama et al., 2008; Courtine et al., 2009). Training had a significant main effect 
on neuronal activity in laminae I-V and total (lamina I/II/III/IV/V/total: p = 
0.001/0.011/0.046/0.003/0.034/0.013, F = 14.0/7.4/4.2/11/5.0/7.0), and antibody had a 
significant main effect on neuronal activity in laminae III-V, the lumbar dorsal 
commissural nucleus (LDCom), the dorsal nucleus (D), and total (lamina 
III/IV/V/LDCom/D/total: p = 0.043/0.005/0.047/0.011/0.045/0.042, F = 
4.5/9.1/4.3/7.4/4.4/4.6) between L2 and L5. The ACsA+ST group showed less 
activity than the ACsA+UT group in lamina IV, the 11C7+UT group showed less 
activity than the ACsA+UT group in lamina IV and LDCom and more activity than 
the 11C7+ST group in laminae I-II, and the 11C7+ST group showed less activity than 
the ACsA+UT group in laminae I-V, the LDCom, the D, and total between L2 and L5 
(Fig. 4a). There was a clear trend toward less neuronal activity with training and anti-
Nogo-A antibody in laminae I-IX, the D, the intermediolateral cell group (IML), the 
LDCom, and throughout the spinal cord at L2-L5 (Fig. 4b). 
 
4. Discussion 
This study examined the effects of anti-Nogo-A antibody treatment applied for 
2 weeks immediately following a large incomplete spinal cord transection and 
intensive training starting 3 weeks post-injury for 8 weeks. The results support the 
hypothesis that sequential combination of Nogo-A suppression and rehabilitative 
training would lead to cumulative improvements in SCI outcomes. 
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4.1 Effects of step training 
Three-week post-injury onset of treadmill training improved step consistency 
and paw position during walking after SCI. It is not surprising that stepping was more 
consistent after animals were trained to walk in stereotyped patterns repeatedly for 8 
weeks, and they probably learned to achieve a more parallel paw position in the 
process. The trained walking ability only marginally transferred to climbing ability, 
and generally transfer of learning from one task to another task requires these tasks to 
be very similar (Raineteau and Schwab, 2001; Harel et al., 2010). Three-week post-
injury onset of training alone did not reduce dragging during the swing phase, which 
we also observed in one-week post-injury onset of training previously (Maier et al., 
2009). Forelimb-hindlimb coordination in locomotor activity was frequent with 
training (BBB score of 13). No detrimental effect on recovery was noticed in one- and 
three-week post-injury onsets of treadmill training (Maier et al., 2009). Our results are 
consistent with previous reports and reinforce the findings that repetitive activation of 
motor pathways leads to beneficial changes in behavior in animals as well as humans 
(Dietz and Harkema, 2004; Edgerton et al., 2008; Fouad and Tetzlaff, 2012; Starkey 
and Schwab, 2012), suggesting that delaying the initiation of rehabilitation up to three 
weeks after lesion is still effective in improving stepping ability. 
Treadmill training promoted CST fiber sprouting that grew caudal to the 
lesion, although less so than anti-Nogo-A antibody treatment in the thoracic region. 
Previous studies have shown that rehabilitative training can increase sprouting of CST 
fibers, which may be induced by up-regulation of growth/plasticity associated factors 
(Ying et al., 2005; Fouad and Tetzlaff, 2012; Joseph et al., 2012). Other descending 
tracts may also contribute to training-induced recovery (Engesser-Cesar et al., 2007; 
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Fouad and Tetzlaff, 2012), although serotonergic pathways did not seem to be 
affected by training alone based on this and our previous study (Maier et al., 2009). 
Descending input to interneurons residing in the deep dorsal and intermediate 
gray is thought to modulate activity of proprioceptive and cutaneous afferents, which 
has been shown to occur through presynaptic inhibition in rhythmic patterns during 
locomotion (Eccles et al., 1962; Jankowska et al., 1981; Dubuc et al., 1988; Perreault 
et al., 1999; Rudomin and Schmidt, 1999). Descending modulation is disrupted along 
with increased afferent fibers and terminals after SCI, which is associated with 
hyperreflexia and spasticity (Nelson and Mendell, 1979; Skinner et al., 1996; 
Raineteau and Schwab, 2001; Tan et al., 2012). Our results show that training not 
only reduced sprouting of afferents in the dorsal and intermediate gray matter but also 
increased CST sprouting in regions where interneurons mediating presynaptic 
inhibition reside (Hughes et al., 2005). Similar to our previous study using electron 
microscopy, training alone did not show an increase in Ia afferent terminations 
apposing alpha motoneurons (Ichiyama et al., 2011). Such increase only occurred 
with anti-Nogo-A antibody treatment. These changes can explain the depressed H-
reflexes and reduced spasticity after training in SCI that have been reported 
previously (Raineteau and Schwab, 2001; Trimble et al., 2001; Fouad and Tetzlaff, 
2012). 
In the present study, we chose to investigate a medial motor pool, which 
putatively contains motoneurons innervating axial musculature. This was done in 
order to avoid possible selection of motoneurons innervating different muscles, 
potentially antagonistic groups. It is likely that activity of all hindlimb motor pools 
(innervating axial, proximal, distal muscles) is involved in changes driven by 
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locomotor training, given the need to control both posture and locomotion during 
stepping.  
Training also reduced neuronal activity in the lumbar spinal cord associated 
with walking, which is in agreement with our previous findings (Ichiyama et al., 2008; 
Courtine et al., 2009). Interestingly, this reduction is similarly observed in areas with 
reduced Ia afferent input after step training. It is possible that these two observations 
are somehow linked, but further experiments are necessary to determine such 
relationship. 
 
4.2 Effects of anti-Nogo-A antibody treatment 
Anti-Nogo-A antibody treatment reduced dragging during the swing phase and 
climbing errors after SCI, which coincides with our previous results (Maier et al., 
2009). However, it only marginally improved step consistency during walking. Anti-
Nogo-A antibody treatment improved paw position during the swing phase on 
average but not at lift off and initial contact, and while paw position was rotated at 
initial contact and lift off, forelimb-hindlimb coordination was consistent in 
locomotor activity (BBB score of 14). Our results suggest that some functions are 
recovered and maintained after several weeks following 2 weeks of anti-Nogo-A 
antibody delivery, but others are lost with time after injury and treatment. 
 Anti-Nogo-A antibody treatment greatly promoted CST fiber sprouting caudal 
to the lesion, as expected (Liebscher et al., 2005; Thuret et al., 2006; Maier et al., 
2009; Starkey and Schwab, 2012); however, most of the fibers did not directly reach 
the lumbar spinal cord. Nevertheless, it is plausible that indirect reconnections 
enabled by anti-Nogo-A antibody helped to reduce dragging and climbing errors, 
because the CST is thought to be important for control of distal musculature necessary 
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to reduce dragging during the swing phase and perform skilled motor tasks(Raineteau 
and Schwab, 2001; Bareyre et al., 2004; Liebscher et al., 2005). Serotonergic 
synapses on motoneurons at L4 did not appear to be affected by anti-Nogo-A 
antibody treatment alone 12 weeks after SCI, whereas in our previous study it was 
found to increase serotonergic fibers and synapses on motoneurons at L3 in similar 
experimental settings 10 weeks after SCI (Maier et al., 2009). It is possible that at the 
specific time points investigated here a retraction of 5-HT varicosities on 
motoneurons was observed, suggesting a dynamic process of sprouting and pruning of 
terminals with treatments (i.e. use and disuse). 
Anti-Nogo-A antibody treatment also increased primary afferent fibers and 
terminals onto motoneurons in the spinal cord caudal to the lesion, clearly 
demonstrating that suppression of the myelin associated neurite growth inhibitory 
protein Nogo-A results in sprouting of fibers and synapse formation from different 
systems in line with previous evidence (Wills et al., 2012; Akbik et al., 2013; 
Petrinovic et al., 2013). Similar observations have been made with other plasticity 
enhancing pharmacological combinations, such as adeno-associated virus encoding 
L1 and chondroitinase ABC (Chase ABC) treatment which increased excitatory 
glutamatergic terminals at motoneuronal somata and pre-motor interneurons (Lee et 
al., 2012). 
Interestingly, anti-Nogo-A antibody treatment reduced neuronal activity 
associated with walking similar to step training, while it increased descending and 
sensory inputs. This regulation of neuronal activity was most prominent in laminae 
III-V, the LDCom, and the D suggestive of significant changes in interneuronal 
processing and integration of descending and afferent information. We speculate that 
the animals with anti-Nogo-A antibody treatment intentionally and/or unintentionally 
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trained themselves in the cage, which helped them to develop a unique strategy for 
functional compensation that was different from treadmill training. 
 
4.3 Effects of sequential therapy 
 Sequentially combined therapy with anti-Nogo-A antibody treatment and 
treadmill training resulted in cumulative functional improvements after SCI; animals 
with sequential therapy showed better step consistency during walking as seen with 
training alone compared to no treatment, and they also showed less dragging during 
the swing phase and fewer climbing errors as seen with anti-Nogo-A antibody 
treatment alone compared to no treatment. In addition, sequential therapy improved 
paw position during walking better than individual treatments. Forelimb-hindlimb 
coordination was consistent, paw position was parallel, and toe clearance was 
frequent in locomotor activity with sequential therapy (BBB score of 17). The 
superior recovery is in contrast to our previous study where one-week post-injury 
onset of treadmill training, overlapping in time with the anti-Nogo-A antibody 
treatment, showed no functional improvement (Maier et al., 2009). It is known that 
the half-life of anti-Nogo-A antibody in cerebrospinal fluid is around 2 days 
(Liebscher et al., 2005) and therefore it is highly unlikely the antibody was still active 
within the spinal cord at the time locomotor training started in the present study. 
These observations strongly suggest that our observed additive effects are due to the 
chronological separation of the interventions. 
 Sequential therapy greatly promoted CST fiber sprouting caudal to the lesion, 
which coincides with simultaneous combination that showed the largest amount of 
CST sprouting just caudal to the lesion previously (Maier et al., 2009). Here, we 
further demonstrate that sequential combination allowed the sprouting fibers to 
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directly extend into the lumbar segments, likely associated with the effects of three-
week post-injury onset of training. It is possible that CST sprouting enabled by anti-
Nogo-A antibody was further enhanced by growth factors up-regulated by training. It 
remains to be determined whether changes in number of observed CST fibers are true 
regenerating axons or sprouting from spared axons because the ACsA+UT group also 
showed some residual CST fibers caudal to the lesion several months after the initial 
injury. Sequential therapy also increased serotonergic synapse numbers onto 
motoneurons at L4, most likely through similar mechanisms. 
The fact that sequential therapy led to lower levels of Ia afferent sprouting and 
synapse formation onto lumbar motoneurons than anti-Nogo-A antibody treatment 
alone, indicates that the augmented sprouting enabled by anti-Nogo-A antibody 
treatment was reduced by step training, probably to stabilize functionally important 
and prune exuberant fibers and synapses (Wahl et al., 2014). This use-dependent 
mechanism may be important for functional locomotion because ectopic sprouting of 
Ia afferents has been shown to lead to spasticity (Liu and Chambers, 1958; Nelson 
and Mendell, 1979; Tan et al., 2012). It is also interesting that similar to our previous 
observations, no changes in allodynia and hyperalgesia were observed. As the lesion 
itself has been shown previously not to induce abnormal sensation, the lack of 
differences between groups strongly suggests our treatments had no effect on these 
parameters (Liebscher et al., 2005; Maier et al., 2009). Locomotor training and anti-
Nogo-A antibody preferentially affected proprioceptive muscle afferents. 
Modulation of neuronal activation associated with walking was most 
pronounced with sequential therapy, where activation of c-fos was lowest compared 
to individual treatments and no treatment especially in laminae III-V. Together with 
the increased sprouting of CST fibers into lumbar segment in deep dorsal horn and 
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intermediate zone of the gray matter and modulation of Ia afferent sprouting, 
integration of proprioceptive information with descending commands could be a key 
mechanism underlying the superior functional recovery in sequential therapy. The 
interactions and interdependence between CST terminations in spinal cord and 
afferent sprouting in deep dorsal horn laminae have recently been shown during 
development and after injury (Chakrabarty and Martin, 2011; Tan et al., 2012). 
This study emphasizes that training onset should follow in time with 
regenerative medicine in combination therapies, which is convenient for clinical 
applications because early training onsets are usually unrealistic in the treatment of 
SCI patients (Fouad and Tetzlaff, 2012). The next steps are to seek potential 
treatments that can add to the present sequential therapy for further cumulative 
improvements, and optimize the related parameters, such as treatment timing, drug 
dose, and training type, frequency, duration and intensity. 
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Figure legends 
Figure 1 Behavioral outcomes (n = 7 per group). Data were obtained from the BBB 
locomotor rating scale (a), walking pattern analysis (b-g), and inclined climbing (h). 
BBB score (offset horizontally for clarity), toe drag, paw position, step consistency, 
and climbing error are presented as mean ± SEM (a, b, d, f, h). Representative 
examples of up-and-down movement of the toe during the swing phase, planar 
movement of the right hind paw during the swing phase from lift off to initial contact, 
and three-dimensional movement of the right hindlimb markers in 10 consecutive 
steps are presented in (c), (e), and (g). *P < 0.05, **P < 0.01. 
 
Figure 2 Supraspinal axons (n = 7 per group). The CST was anterogradely traced with 
BDA on the right side. CST axons projected caudally in the dorsal, lateral, and ventral 
funiculi at C7 (a). BDA labeling is displayed in grayscale for clarity. Past the lesion 
site, sprouting CST fibers grew transversely from rostral (R) to caudal (C) in a 
preferred direction in the WM (b). The growing direction of CST fibers became 
mainly transverse in and across the GM (c). CST fibers could grow across the midline 
near the central canal (CC) in the ACsA+ST and 11C7+ST groups (d). Normalized 
number of BDA labeled fibers at T13 and L1 is presented in (e). The L1 to T13 CST 
fiber ratio is presented in (f). Location of the CST fibers is schematically represented 
in (g). 5-HT positive varicosity density on large motoneurons is presented in (h). Data 
are presented as mean ± SEM (e,f,h). *P < 0.05, **P < 0.01, ***P < 0.001. Scale bar: 
20 μm. 
 
Figure 3 Primary afferents (n = 7 per group). Three ROIs were placed on each side of 
the gray matter at L2 to measure the VGluT1 positive dots (red: VGluT1, green: 
 34 
ChAT); a dorsal ROI (300 x 130 μm2) was positioned next to the medial side of the 
dorsal horn in laminae III-IV, an intermediate ROI (300 x 300 μm2) was positioned 
near the dorsal CST covering the VGluT1 cluster, and a ventral ROI (200 x 200 μm2) 
was centered on the motoneurons in the medial ventral horn (a). Normalized VGluT1 
positive puncta density in the ROIs is presented in (b). Representative images of the 
ROIs with VGluT1 staining are displayed in grayscale for clarity in (c). Number of 
VGluT1 positive bouton in close apposition to large motoneuron somata and proximal 
dendrites is presented in (d). Data are presented as mean ± SEM (b,d). *P < 0.05, **P 
< 0.01, ***P < 0.001. Scale bar: 100 μm. 
 
Figure 4 Neuronal activity associated with walking (n = 7 per group). Number of c-
fos positive neurons between L2 and L5 is presented in (a). Representative camera 
lucida drawings and number of c-fos positive neurons at L2, L3, L4, and L5 are 
presented in (b). Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 
0.001. 
 
